ABMD – ABIOMED, Inc. – Fundamental analysis, financial statements, key ratios, and fair value analysis

ABIOMED, Inc.

Healthcare
Medical Devices
313.44
11.15
3.69%
449.75
207.8
Stock Current Price
Change
Change %
52 Week High
52 Week Low

Financial Ratios

Earnings per Share (EPS)4.13
EPS Estimate Currrent Qtr0.93
Book Value Per Share17.61
Market Cap 14 Billion
PE Ratio 74.4
Dividend YieldNA

Stock Yield

Stock Return 7 Days13.20%
Stock Return 15 Days6.49%
Stock Return 30 Days -7.36%
Stock Return 3 Months-25.86%
Stock Return One Year65.29%
Stock Return 3 Years68.86%

Stock Technical Analysis

Relative Strengh Index (14)39.89
Average True Range (14)17.27
Momentum (14)-28.4
Simple Moving Average (14) -28.4
Time Series Forecast (14)301.4
Time Series Forecast (30) 337.39

Stock News

Financial Statements

index2015201620172018
Revenue230 Million330 Million445 Million594 Million
Cost of Revenue40 Million50 Million71 Million99 Million
Gross Profit190 Million279 Million375 Million495 Million
Gross Margin (%)82.66%84.70%84.14%83.40%
Selling General and Administrative Expense126 Million164 Million218 Million263 Million
Other operating expenses36 Million49 Million65 Million72 Million
Earning Before Interest and Taxes EBIT29 Million66 Million91 Million160 Million
EBIT/Operating Margin (%)12.49%19.98%20.51%27.02%
Interest Expense0000
Other non-operating expenses/income0000
Earnings before Tax29 Million66 Million91 Million160 Million
Income Tax Expense-85 Million28 Million39 Million48 Million
Net Income114 Million38 Million52 Million112 Million
Net Margin (%)49.36%11.58%11.70%18.89%
Earnings per share from operating income0.09547812.030471.498020.583797
Earnings per Diluted Share2.650.851.172.45
Dividends per Basic Common Share0000
Weighted average number of shares outstanding43 Million45 Million45 Million46 Million
index2017 Q42018 Q12018 Q22018 Q3
Revenue154 Million174 Million180 Million182 Million
Cost of Revenue25 Million30 Million31 Million30 Million
Gross Profit129 Million144 Million149 Million152 Million
Gross Margin (%)83.77%82.75%82.86%83.58%
Selling General and Administrative Expense67 Million76 Million81 Million79 Million
Other operating expenses17 Million20 Million20 Million21 Million
Earning Before Interest and Taxes EBIT46 Million49 Million48 Million52 Million
EBIT/Operating Margin (%)29.64%27.81%26.94%28.51%
Interest Expense0000
Other non-operating expenses/income0000
Earnings before Tax46 Million49 Million48 Million52 Million
Income Tax Expense32 Million12 Million-42 Million2 Million
Net Income13 Million37 Million90 Million50 Million
Net Margin (%)8.73%21.12%50.03%27.58%
Earnings per share from operating income11.70811.645550.2760770.948655
Earnings per Diluted Share0.290.81.951.09
Dividends per Basic Common Share0000
Weighted average number of shares outstanding46 Million46 Million46 Million46 Million
index2015201620172018
Cash and Equivalents22 Million48 Million39 Million43 Million
Trade and Non Trade Receivables32 Million43 Million54 Million70 Million
Inventory17 Million27 Million35 Million50 Million
Other current assets159 Million267 Million277 Million417 Million
Current Assets185 Million288 Million327 Million494 Million
Total Non-Current Assets153 Million136 Million223 Million292 Million
Total Assets338 Million424 Million550 Million786 Million
Trade and Non Trade Payables10 Million9 Million21 Million24 Million
Other current liabilities29 Million37 Million49 Million61 Million
Current Liabilities39 Million47 Million70 Million85 Million
Liabilities Non Current7 Million9 Million29 Million12 Million
Accumulated Retained Earnings Deficit-137 Million-99 Million-47 Million140 Million
Shareholder’s equity other429 Million468 Million499 Million549 Million
Shareholders Equity292 Million369 Million452 Million690 Million
Noncontrolling interests79 Million93 Million139 Million169 Million
Total Assets338 Million424 Million550 Million786 Million
index2017 Q42018 Q12018 Q22018 Q3
Cash and Equivalents51 Million43 Million61 Million76 Million
Trade and Non Trade Receivables65 Million70 Million68 Million74 Million
Inventory47 Million50 Million56 Million64 Million
Other current assets361 Million417 Million435 Million500 Million
Current Assets422 Million494 Million497 Million562 Million
Total Non-Current Assets297 Million292 Million315 Million326 Million
Total Assets720 Million786 Million812 Million887 Million
Trade and Non Trade Payables22 Million24 Million26 Million22 Million
Other current liabilities53 Million61 Million51 Million60 Million
Current Liabilities75 Million85 Million77 Million82 Million
Liabilities Non Current12 Million12 Million12 Million12 Million
Accumulated Retained Earnings Deficit104 Million140 Million231 Million281 Million
Shareholder’s equity other529 Million549 Million493 Million512 Million
Shareholders Equity632 Million690 Million723 Million793 Million
Noncontrolling interests151 Million169 Million153 Million164 Million
Total Assets720 Million786 Million812 Million887 Million
index2015201620172018
Net Cash Flow from Operations43 Million77 Million115 Million193 Million
Capital Expenditure-5 Million-16 Million-50 Million-56 Million
Net Cash Flow from Investing-50 Million-58 Million-126 Million-181 Million
Net Cash Flow from Financing10 Million7 Million4 Million-9 Million
Cash and Equivalents22 Million48 Million39 Million43 Million
index2017 Q42018 Q12018 Q22018 Q3
Net Cash Flow from Operations57 Million56 Million47 Million61 Million
Capital Expenditure-26 Million-12 Million-15 Million-12 Million
Net Cash Flow from Investing-52 Million-68 Million35 Million-50 Million
Net Cash Flow from Financing2 Million3 Million-62 Million4 Million
Cash and Equivalents51 Million43 Million61 Million76 Million

Stock Price History

table